MELISSA KARRH: Open Payments
NPI 1720402936 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,944 in 150 payments from 19 companies in 2025. Trend: 2023 $12,130 · 2024 $11,538 · 2025 $17,944
Speaker / faculty: $11,055Consulting: $3,188Food & beverage: $2,554Travel & lodging: $1,068Education: $80
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $8,544 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 38 | $7,596 |
| Vanda Pharmaceuticals Inc. | 16 | $381 |
| Supernus Pharmaceuticals, Inc. | 13 | $279 |
| Teva Pharmaceuticals USA, Inc. | 10 | $219 |
| Corium, LLC | 9 | $209 |
| Tris Pharma Inc | 6 | $124 |
| Axsome Therapeutics, Inc. | 7 | $117 |
| Lundbeck LLC | 4 | $89 |
| Alkermes, Inc. | 5 | $89 |
Products named: VRAYLAR, CAPLYTA, FANAPT, Qelbree, Azstarys, REXULTI, AUSTEDO XR, Dyanavel XR.
Industry payments across AL — which companies pay providers there.
